German (DAX) Life Sciences Industry Analysis

UpdatedFeb 25, 2026

DataAggregated Company Financials

Companies6

7D1.8%
3M-6.8%
1Y-18.9%
YTD-5.8%

Over the last 7 days, the Life Sciences industry has gained 1.8%. In the same time, Gerresheimer was down 12%. However, the industry is down 19% over the past year. As for the next few years, earnings are expected to grow by 23% per annum.

Industry Valuation and Performance

Has the German Life Sciences Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Thu, 26 Feb 2026	€18.5b	€7.5b	€168.6m	27.6x	110x	2.5x
Sat, 24 Jan 2026	€20.2b	€7.5b	€143.5m	40.1x	141x	2.7x
Mon, 22 Dec 2025	€18.8b	€7.5b	€143.5m	39.9x	131.3x	2.5x
Wed, 19 Nov 2025	€18.4b	€7.5b	€143.9m	36.3x	127.5x	2.4x
Fri, 17 Oct 2025	€19.5b	€7.5b	€117.9m	40.1x	165.7x	2.6x
Sun, 14 Sep 2025	€17.9b	€7.4b	€157.8m	23.1x	113.3x	2.4x
Tue, 12 Aug 2025	€17.9b	€7.4b	€107.0m	24.9x	167.4x	2.4x
Thu, 10 Jul 2025	€20.4b	€7.3b	€114.9m	26.2x	177.6x	2.8x
Sat, 07 Jun 2025	€20.0b	€7.3b	€114.9m	28.7x	174.2x	2.7x
Mon, 05 May 2025	€22.0b	€7.3b	€112.4m	28.2x	195.5x	3x
Wed, 02 Apr 2025	€20.4b	€7.1b	€156.5m	26.2x	130.1x	2.8x
Fri, 28 Feb 2025	€23.0b	€7.1b	€156.5m	28.1x	147.2x	3.2x
Sun, 26 Jan 2025	€22.7b	€7.1b	€169.8m	23.4x	133.5x	3.2x
Tue, 24 Dec 2024	€21.2b	€7.1b	€169.8m	24.9x	124.7x	3x
Thu, 21 Nov 2024	€21.1b	€7.1b	€170.5m	26.4x	124x	3x
Sat, 19 Oct 2024	€25.2b	€7.1b	€171.2m	31.1x	147.1x	3.6x
Mon, 16 Sep 2024	€24.7b	€7.1b	€172.8m	32.4x	143x	3.5x
Wed, 14 Aug 2024	€24.0b	€7.0b	€237.1m	35.9x	101.3x	3.4x
Fri, 12 Jul 2024	€25.2b	€7.0b	€309.8m	36.3x	81.4x	3.6x
Sun, 09 Jun 2024	€24.7b	€7.0b	€333.3m	31.8x	74.2x	3.5x
Tue, 07 May 2024	€28.2b	€7.0b	€340.1m	35.4x	83.1x	4x
Thu, 04 Apr 2024	€33.5b	€7.1b	€384.5m	37.9x	87.2x	4.7x
Sat, 02 Mar 2024	€33.8b	€7.1b	€378.2m	39.1x	89.3x	4.8x
Mon, 29 Jan 2024	€31.6b	€7.3b	€516.3m	33.5x	61.2x	4.3x
Wed, 27 Dec 2023	€32.5b	€7.3b	€507.1m	35.2x	64.1x	4.5x
Fri, 24 Nov 2023	€28.0b	€7.3b	€507.1m	29.1x	55.3x	3.9x
Sun, 22 Oct 2023	€21.4b	€6.4b	€353.3m	38.9x	60.5x	3.3x
Tue, 19 Sep 2023	€28.2b	€6.6b	€498.1m	40x	56.6x	4.3x
Thu, 17 Aug 2023	€30.6b	€6.6b	€425.8m	44.7x	71.9x	4.7x
Sat, 15 Jul 2023	€27.0b	€6.8b	€496.6m	36.1x	54.4x	4x
Mon, 12 Jun 2023	€28.0b	€6.7b	€487.3m	38.8x	57.5x	4.2x
Wed, 10 May 2023	€27.7b	€6.7b	€483.0m	38.3x	57.4x	4.2x
Fri, 07 Apr 2023	€30.8b	€6.7b	€594.3m	34.3x	51.8x	4.6x
Sun, 05 Mar 2023	€30.5b	€6.7b	€594.3m	34.6x	51.4x	4.6x

Price to Earnings Ratio

51.4x

Sun, 05 Mar 2023

Current Industry PE

Investors are optimistic on the German Life Sciences industry, and appear confident in long term growth rates.

The industry is trading at a PE ratio of 110x which is higher than its 3-year average PE of 106x.

The 3-year average PS ratio of 3.5x is higher than the industry's current PS ratio of 2.5x.

Past Earnings Growth

The earnings for companies in the Life Sciences industry have declined 34% per year over the last three years.
Meanwhile revenues for these companies have grown 4.1% per year.
This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.